Showing results (1891-1900 of 2,360) with videos related to
Sort By:
Pageof 236
Breast Cancer Research : BCR|June 12, 2023
XENERA-1: a randomised double-blind Phase II trial of xentuzumab in combination with everolimus and exemestane versus everolimus and exemestane in patients with hormone receptor-positive/HER2-negative metastatic breast cancer and non-visceral diseasePeter Schmid, Javier Cortes, Ana Joaquim, et al.Frontiers in Immunology|May 19, 2023
Risk factors and characteristics influencing humoral response to COVID-19 vaccination in patients after allogeneic stem cell transplantationMarie Luise Hütter-Krönke, Adela Neagoie, Igor Wolfgang Blau, et al.Leukemia|June 25, 2024
How risky is a second allogeneic stem cell transplantation?Olaf Penack, Mouad Abouqateb, Christophe Peczynski, et al.Nature|December 1, 2025
Sustained HIV-1 remission after heterozygous CCR5Δ32 stem cell transplantationChristian Gaebler, Samad Kor, Kristina Allers, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 8, 2018
Role of Donor Clonal Hematopoiesis in Allogeneic Hematopoietic Stem-Cell TransplantationMareike Frick, Willy Chan, Christopher Maximilian Arends, et al.Pediatric Neurology|March 31, 2019
6-Pyruvoyltetrahydropterin Synthase Deficiency: Review and Report of 28 Arab SubjectsMohammed Almannai, Rana Felemban, Mohammed A Saleh, et al.Genetics in Medicine : Official Journal of the American College of Medical Genetics|December 15, 2021
Accurate assignment of disease liability to genetic variants using only population dataJoseph M Collaco, Karen S Raraigh, Joshua Betz, et al.BMC Cancer|September 13, 2021
Influence of migrant background on patient preference and expectations in breast and gynecological malignancies (NOGGO-expression V study): results of a prospective multicentre study in 606 patients in GermanyD Dimitrova, B Naghavi, R Richter, et al.Developmental Cell|January 29, 2020
Metabolic Control over mTOR-Dependent Diapause-like StateAbdiasis M Hussein, Yuliang Wang, Julie Mathieu, et al.Pathology, Research and Practice|March 29, 2014
Detection of an activated JAK3 variant and a Xq26.3 microdeletion causing loss of PHF6 and miR-424 expression in myelodysplastic syndromes by combined targeted next generation sequencing and SNP array analysisKristin Kunze, Ulrike Gamerdinger, Jacqueline Leßig-Owlanj, et al.Pageof 236